By John Meyer, consultant in financial affairs – Eurasia Business News, August 26, 2025. Article no. 1743

Advanced Micro Devices (AMD): AMD’s stock closed at $166.62, up about 2%, trading on NASDAQ. The stock has been active with a market cap around $270 billion and a year range from about $76 to $187.

Eli Lilly (LLY): Eli Lilly shares surged over 4-5% on Tuesday following positive results from the Phase 3 trial of its oral weight-loss drug, orforglipron. The drug showed patients lost on average 10.5% of their body weight and reduced blood sugar levels, meeting key trial goals. The company is now preparing to seek FDA approval. Despite earlier declines over competition and insurance concerns, the promising data has sparked a rebound in investor confidence, with the stock trading near $730 and gaining nicely on the day.

EchoStar (SATS): EchoStar shares soared over 70% following a $23 billion deal to sell wireless spectrum licenses to AT&T. EchoStar will also operate as a hybrid mobile network under Boost Mobile. This massive deal drove the stock’s explosive gains, pushing it into a year-to-date gain of over 130%.

Trump Media & Technology Group (DJT): Trump Media shares rose about 5% on Tuesday, trading near $18, following renewed attention after President Trump’s announcements about central bank leadership changes. The stock shows some volatility amid political news.

NovaBay Pharmaceuticals (NBY):
NovaBay Pharmaceuticals announced a significant one-time special cash dividend of $0.80 per share, payable on September 29, 2025. This dividend represents a strong commitment to returning value to shareholders amid strategic alternatives being explored by the company. NovaBay’s stock was trading around $0.90 on that day, with a recent high of $1.25 in the past year. The company’s market cap was relatively small, and despite some recent volatility, the cash dividend announcement was a positive catalyst signaling potential restructuring or changes ahead.

Read also : Tax Management strategies for Digital Nomads

MongoDB (MDB):
MongoDB surged over 23% on August 26 after reporting a strong Q2 earnings beat with earnings of $1 per share versus the expected 66 cents and revenue of $591 million, surpassing forecasts. Growth in its Atlas cloud subscription service and added customers fueled optimism, leading to raised guidance for the rest of fiscal 2026. This strong financial performance positioned MongoDB as a key stock to watch due to its robust cloud business and expanding customer base.

Read also : Gold : Build Your Wealth and Freedom

Salarius Pharmaceuticals (SLRX):
Salarius Pharmaceuticals experienced a stock increase of over 17% in after-hours trading on August 26, reaching about $6.77 per share from the day’s close near $5.76. This move stood out after the company highlighted positive developments in its oncology-focused drug pipeline. Although it remains a smaller player with a lower market cap, the stock’s momentum was driven by investor interest in its innovative cancer therapies and potential upcoming catalysts.

Advertisements

Our community already has 155,000 readers, joins us !

Subscribe to our Telegram channel

Follow us on TelegramFacebook and Twitter

© Copyright 2025 – Eurasia Business News. Article no. 1743